Articles > Devices & Technology

  1. FreeStyle Libre Will be Covered by Medicare

    Abbott’s device will join the Dexcom G5 as the only continuous glucose monitoring systems covered under the federal program. On January 4th, 2018, Abbott Laboratories announced it had received word that its FreeStyle Libre System will be covered by Medicare. The Centers for Medicare and Medicaid Services (CMS) ruled that the new glucose monitoring system, […]

    Read More
  1. Patients as Partners in Medical R&D

    Medical devices and therapies must go through a series of rigorous clinical trials in order to prove they are safe and effective for patient use. But more and more companies are looking at patient-reported outcomes (PRO) on a larger scale to ensure the solutions they are developing are sustainable, affordable, and accessible for people living […]

    Read More
  2. Patient Panelist Spotlight: Bunny Kasper

    Wrapping up our spotlight series on the patient panelists appearing at this week’s T1D Exchange Annual Meeting, we introduce Bunny Kasper. Bunny is an active diabetes advocate and JDRF volunteer from Hamden Connecticut. As a married mother of three sons and nine grandchildren (two of whom also have type 1 diabetes), Bunny was misdiagnosed for […]

    Read More
  1. Medtronic Issues Urgent Device Recall Information for MiniMed Infusion Sets

    Medtronic has become aware of recent reports of potential over-delivery of insulin shortly after an infusion set change. Over-delivery of insulin can cause hypoglycemia and in extreme cases, death. Medtronic has received reports of hypoglycemia requiring medical intervention potentially related to this issue. Are your MiniMed infusion sets part of the recall? We urge you […]

    Read More
  2. ADA Scientific Sessions: First Impressions from a Newbie

    I started working at T1D Exchange a year ago, and this year was my first time attending the American Diabetes Association’s Scientific Sessions. I must say, as someone with type 1 diabetes, I was excited to be surrounded by researchers and endocrinologists who might share some breakthrough research that would take us closer to better […]

    Read More
  3. I Chose Type 1 Diabetes and It Changed My Life for the Better

    One of our Glu Ambassadors, Sandy Brooks, has been attended our in-person educational programs and been a big advocate for T1D Exchange for the past few years. Today she is sharing her very unique story of how and why she acquired type 1 diabetes. I’m a “surgical type 1” person with diabetes (PWD). I acquired […]

    Read More
  4. A Day without My CGM: I Couldn’t Do It

    I couldn’t do it. I couldn’t go a day—wait, let’s be real here—more than four hours without my continuous glucose monitor (CGM). Why? Okay, maybe because I’m nearly eight months pregnant and knowing each single number is critical to not only my health, but my child’s, but holy moly I’m addicted to that info. I even […]

    Read More
  5. Polyphotonix Offers An Innovative Vision for Treating Retinopathy

    Last fall, T1D Exchange held its 1st Annual Diabetes Innovation Challenge, an open competition seeking novel treatments for diabetes. The competition introduced our partners and collaborators from industry, academic research, other diabetes nonprofits, clinical partners and patient/caregiver community to over 60 groundbreaking diabetes therapies or technologies currently in development. One of these applicants, UK-based Polyphotonix, […]

    Read More
  6. Together We’re Fighting for the Next Generation of Innovators

    When the type 1 community comes together, we’re louder, stronger, and more powerful. T1D Exchange is a unique nonprofit that combines our collective voices to demand better treatments and better care. This week, we are highlighting the various ways in which our community has made a difference…Together One. We live in an amazing time of […]

    Read More